FDA
Deputy Commissioner Dr. Lester Crawford and Dr. Joseph Jasinski of IBM
Life Sciences to give keynote presentations at 3rd Annual Biotech Industry
Conference
New
York, April 22, 2003 --
The Wall Street Transcript (www.twst.com/conferences)
announced today that FDA Deputy Commissioner Dr. Lester Crawford and Dr.
Joseph Jasinski will give keynote presentations at its “Third Annual
Biotechnology Industry Conference”, to be held May 15, 2003, at The
Harvard Club in New York City.
The
one-day event, sponsored by McDonnell Boehnen Hulbert & Berghoff and
Kirkpatrick & Lockhart LLP, also includes four roundtable discussions
covering the most vital topics in the Biotechnology field. Single
presentations will also discuss and explore IP and Strategic Development
Transactions.
Participating
experts will include:
·
Senior
biotech executives
from Genzyme, Avalon Pharmaceuticals, Therion Biologics, Genzyme Molecular
Oncology, Raven Biotechnologies, Iomai Corp., SIGA Technologies, Altair
Nanotechnologies, Nanosphere, Rubicon Genomics, and more;
·
Venture
capitalists and financial professionals
from JP Morgan, Leerink Swann, Oxford Bioscience Partners, Bioventures
Investors, Standard & Poors, Private Raise, HealthCare Ventures, Punk
Ziegel, Lux Capital, and more.
Partnering
organizations for the “Third Annual Biotechnology Industry Conference”
include: Ronald Trahan Associates (“RTA”) Inc., NYBA, Fierce Biotech,
Drug Discovery Technology, Jenks HBR, The Pink Sheet, Espicom, PharmaVoice,
Thomson Current Drugs Ltd, MedAdNews, VertMarkets, BioVenture View,
vFinance, Bio IT World, Drugdel, HealthconCorp, CanBiotech and
Biotechnology Investment Today.
For
complete conference information, please visit www.twst.com/conferences,
or call 212-952-7454.
#
# # # #
The
Wall Street Transcript
67
Wall Street, 16th Floor
New
York, NY 10005
Contact:
Joanna
Grossman, 212-952-7454, joanna@twst.com
